Details Basic Details Status Ongoing Last Updated Wednesday, April 21, 2021 Original Posting Date Wednesday, April 21, 2021 Health Outcome(s) angioedema Purpose Drug and Outcome Analysis Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR Yes Analytic Code Link(s) (1) Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis